Market Closed -
Nasdaq
16:00:00 2025-02-14 EST
5-day change
1st Jan Change
100.24 USD
-1.51%
-9.74%
-24.99%
Illumina Starts Pilot Program With Partners to Generate Proteomics Data
January 13, 2025 at 04:44 am
Carl Icahn Cuts Shared Share Stake In Southwest Gas Holdings, Illumina
02-14
RE
Illumina says conducted candid, proactive communication with China's Commerce Ministry
02-09
RE
Sector Update: Health Care Stocks Lower in Late Afternoon Trading
02-07
MT
Sector Update: Health Care Stocks Lower Friday Afternoon
02-07
MT
RBC Capital Adjusts Price Target on Illumina to $247 From $250, Keeps Outperform Rating
02-07
MT
Sector Update: Health Care Stocks Lower Pre-Bell Friday
02-07
MT
The Employment Enigma
02-07
Analysts recommendations: Aj Bell, GSK, Anglo American, Eli Lilly, Expedia…
02-07
Analysts recommendations: Air Products & Chemicals, AMD, Elf Beauty, Eli Lilly, Expedia…
02-07
Illumina Q4 Non-GAAP Earnings Rise, Revenue Falls; 2025 Outlook Set; Shares Drop After Hours
02-06
MT
Illumina forecasts 2025 revenue largely below estimates
02-06
RE
Illumina, Inc., Q4 2024 Earnings Call, Feb 06, 2025
02-06
Earnings Flash (ILMN) ILLUMINA INC. Posts Q4 Revenue $1.10B, vs. FactSet Est of $1.09B
02-06
MT
Earnings Flash (ILMN) ILLUMINA INC. Posts Q4 Adjusted EPS $0.95, vs. FactSet Est of $0.91
02-06
MT
Illumina, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 29, 2024
02-06
CI
China considers probe into Apple's App Store fees, practices, Bloomberg News reports
02-05
RE
Wall Street rises on US-China trade optimism, energy boost
02-04
RE
Wall Street gains on US-China trade optimism, energy boost
02-04
RE
PVH, Illumina Added to China's Unreliable Companies List by Ministry
02-04
MT
S&P 500 gains on energy boost; Trump-Xi talks in focus
02-04
RE
Top Midday Stories: China Retaliates With Tariffs, Antitrust Probe of Google; Merck Shares Tumble on Downbeat Guidance
02-04
MT
S&P 500, Nasdaq rise as megacaps charge ahead; tariffs in focus
02-04
RE
Illumina, PVH shares drop as China threatens companies with sanctions
02-04
RE
Shares of Calvin Klein-parent PVH and Illumina fall after China targets companies
02-04
RE
Wall St set for subdued open after China's retaliatory tariffs
02-04
RE
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
ILMN: Dynamic Chart
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows:
- product sales (84.1%): tools and instruments for sequencing, genotyping, genetic expression, etc.;
- sales of services (15.9%).
Net sales are distributed geographically as follows: the United States (52.4%), Americas (3.6%), Europe (25.3%), Asia/Pacific/Middle East/Africa (10.2%) and China/Taiwan/Hong Kong (8.5%).
More about the company
Last Close Price
100.24 USD
Average target price
147.56 USD
Spread / Average Target
+47.21%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1